Activins A, AB, and B inhibit hepatocyte growth factor synthesis by MRC-5 human lung fibroblasts

Biol Pharm Bull. 2002 Nov;25(11):1405-8. doi: 10.1248/bpb.25.1405.

Abstract

The effect of activins A, AB, and B on hepatocyte growth factor (HGF) synthesis stimulated by 12-O-tetradecanoylphorbol beta-acetate (TPA) was studied in MRC-5 human lung fibroblasts. Activins A, AB, and B inhibited the increase in HGF secretion induced by TPA in different dose-dependent manners and potencies. At 5 ng/ml, activins A and AB inhibited the increase approximately 30% and 10%, respectively, and at 25 ng/ml both activins produced almost maximal inhibition, i.e., approximately 40%. Activin B caused 10% inhibition at 12 ng/ml, and at 25 ng/ml produced almost maximal inhibition, approximately 30%. Further analysis with activin A indicated that the inhibition was caused by decreased HGF mRNA levels, followed by decreased cellular HGF levels. At 25 ng/ml, activin A inhibited the increase in HGF in the cellular lysate and the increase in HGF mRNA level approximately 80% and 40%, respectively.

MeSH terms

  • Activins / pharmacology*
  • Activins / physiology
  • Animals
  • Cell Line
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Hepatocyte Growth Factor / antagonists & inhibitors*
  • Hepatocyte Growth Factor / biosynthesis
  • Humans
  • Inhibin-beta Subunits / pharmacology*
  • Inhibin-beta Subunits / physiology
  • Lung / cytology
  • Lung / drug effects*
  • Lung / metabolism
  • Swine

Substances

  • activin A
  • activin B
  • inhibin beta A subunit
  • Activins
  • Hepatocyte Growth Factor
  • Inhibin-beta Subunits